in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Shasun gains FDA and Brazilian Anvisa approvals for Puducherry plant
12:10 PM MDT | July 17, 2013 | Natasha Alperowicz
Shasun Pharmaceuticals (Chennai, India), a leading producer of active pharmaceutical ingredients and formulations catering for global customers, says it completed the US FDA inspection during the last week in June to gain approval for certain products that have been commercially launched by its undisclosed customer in the United States. The inspection concluded that the facility, systems, and practices comply with FDA requirements. Shasun tells CW that the plant is based at Puducherry and is a formulation facility. The plant has also undergone a Brazilian...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee